Compound Screening TRIZ Cases

A deterministic single cell culture system distributes individual cells into three-dimensional microwells for precise isolation.

Segmented AQP4 peptides inhibit pathogenic T cell proliferation to manage neuromyelitis optica relapses without broad immunosuppression side effects.

Segmenting bifunctional imide compounds into distinct binding moieties overcomes the difficulty of targeting large protein-protein interaction surfaces.

Patient-derived tumour explants embed in nanofibrillar cellulose hydrogel matrices to preserve immune cell profiles.

Human embryonic stem cells generate metabolite profiles to identify teratogenic effects in candidate pharmaceutical compounds.

Macrocyclic peptides form a pseudo bicyclic structure via noncovalent hydrophobic interactions to enable cell membrane penetration.

Antibodies bind specifically to the Kir channel turret region to modulate ion channel activity without cross-reacting with other channel subtypes.

Acoustic flow cytometry detects microbial morphology changes to determine antimicrobial susceptibility without culture delays.

Engrafting human glial progenitor cells into immunodeficient mice creates a chimeric model supporting in vivo viral replication.

A cancer diagnostic marker panel detects breast cancer through protein expression profiling.

Genetically modified Caenorhabditis elegans models human protein aggregation disorders using fluorescent fusion proteins for high-throughput drug screening.

Targeting T1R2 receptors in skeletal muscle restores nutrient sensing uncoupling, improving glucose tolerance while preventing muscle mass loss.

Second harmonic generation detects conformational changes in intrinsically disordered proteins to identify drug candidates.

A synthetic mixed culture of defined bacterial strains mimics natural skin microbiomes for in vitro compound bioactivity assessment.

Acetylation status of mitochondrial proteins serves as a reliable biomarker for detecting frataxin deficiency.

Fluorescent viral surrogate nanoparticles replace live viruses for clearance validation, reducing costs and time while maintaining representativeness.

L-nucleic acid spiegelmers resist nuclease degradation without toxic modifications while maintaining high binding affinity through stereochemical inversion.

U83A polypeptides address limited therapeutic options by providing versatile agonist and antagonist activity against multiple cytokine receptors.

Segmentation and intermediary agents streamline nRNA-YY1 complex isolation, enabling targeted cancer therapy discovery.

A method distinguishes deleterious oral bacteria from beneficial species using gingival cell indicator compounds.

Fluorescence quantitative PCR detects ERH gene expression to resolve low diagnostic sensitivity and specificity in early bladder cancer identification.

Histamine 2 receptor antagonists modulate liver macrophage activity to decrease pro-inflammatory cytokine expression.

Neutralizing antibodies against LukE and LukD proteins inhibit cytotoxicity to overcome antibiotic resistance in Staphylococcus aureus infections.

Nucleic acid interacting motif bridges modified proteins and oligomer probes to resolve measurement precision versus assay complexity trade-offs.

A genetic testing method predicts individual response to the calcimimetic drug cinacalcet by analyzing calcium-sensing receptor polymorphisms.

An imidazole dipeptide agent derived from natural sources improves mental function and prevents cerebral atrophy.

Sialylated IgG Fc binds DC-SIGN to trigger anti-inflammatory signaling, resolving side effects from high-dose IVIG through targeted α2,6 linkage modulation.

Active transglutaminase 3 measurement enables precise scalp condition diagnosis.

Antibody targets amino acids 269-288 of Vasohibin-2, blocking angiogenesis and reducing tumor growth.

GC-MS identifies cannabinoids and terpenes while microfluidic bioassays replace slow mechanical calcium measurements with rapid optical detection.

A gallinaceous embryo model enables rapid cancer cell migration analysis through defined tissue grafting.

EDDMMEVPY peptide sequence binds integrin alpha9beta1 with higher affinity than tenascin-C, resolving low binding affinity limitations.

Co-expressing SUMF1 in CHO-K1 cells prevents enzyme loss to lysosomes, yielding high concentrations of active phosphorylated sulfatase.

Antibodies targeting CCX-CKR2 enable precise detection of expressing cells and identification of competing modulators.

Fused tricyclic ring compounds overcome insufficient kinase modulation by inducing apoptosis and inhibiting angiogenesis.

Three-dimensional renal tubule model mimics native tissue architecture to predict human in vivo responses and reduce drug attrition rates.

Plant extracts activate the IRS2 branch of insulin signaling to enhance cellular insulin sensitivity.

A BRETFect bioluminescence system transfers energy through luciferase and fluorescent proteins to monitor protein complexes in live cells.

Atazanavir and artesunate modulate rpL35-dependent translation to increase functional protein levels, addressing toxicity issues in genetic disease therapy.

A chimeric olfactory receptor system with modified N-terminal and IC4 domains enhances cyclic AMP generation in lipid bilayer membranes.

S-adenosylmethionine synthase inhibitors stimulate erythropoiesis via MAT2A enzyme modulation, reducing transfusion dependence in refractory anemia.

Modifying CD137 and NKG2D cytoplasmic tails reduces toxic cytokine production in CAR-T therapies without compromising tumor cell killing efficiency.

Fluorescent probes detect von Hippel-Lindau ligands through emission changes, resolving low sensitivity in conventional assays.

Peptide arrays bind patient antibodies to form immunosignatures, resolving subjective diagnosis and improving accuracy.

Estimates compound activity percentages using noise distributions from control samples, resolving measurement precision issues caused by assay noise.

Co-expressing class XIV myosin components with co-chaperones overcomes the loss of functional activity in traditional systems.

Specific amino acid mutations in G-alpha proteins alter GTPase kinetics, enabling high-throughput detection of RGS GAP activity without radioactive materials.

Engineered yeast cells expressing human ApoE proteins identify genetic suppressors of toxicity without compromising cell viability.